The technology developed by 4ces B.V., a spin-off from Leiden University, reveals how effective these potential medicines are at an early stage of drug development. www.universiteitleiden.nl/en/news/2026...
Toegang geblokkeerd / Access Blocked
universiteitleiden.nl